Patients' expectations of the benefits and harms of treatments, screening, and tests a systematic review

JAMA Internal Medicine

Volumn 175, Issue 2, 2015, Pages 274-286

  Hoffmann, Tammy C ^a,b  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SURGERY; EXPECTATION; HUMAN; MATERNAL CARE; MULTIPLE CHOICE TEST; PATIENT CARE; PATIENT HARM; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SCREENING TEST; UNITED STATES; HEALTH SERVICE; MASS SCREENING; PATIENT ATTITUDE; PSYCHOLOGY;

HEALTH SERVICES MISUSE; HUMANS; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 84922267923     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.6016     Document Type: Review

References (94)

1. Martin AB, Lassman D,Washington B, Catlin A; National Health Expenditure Accounts Team. Growth in US health spending remained slow in 2010; health share of gross domestic product was unchanged from 2009. Health Aff (Millwood). 2012; 31(1):208-219.
2. Lipitz-Snyderman A, Bach PB. Overuse of health care services: when less is more more or less. JAMA Intern Med. 2013;173(14):1277-1278.
3. Korenstein D, Falk R, Howell EA, Bishop T, Keyhani S. Overuse of health care services in the United States: an understudied problem. Arch Intern Med. 2012;172(2):171-178.
4. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: howto stop harming the healthy. BMJ. 2012;344:e3502.
5. Grady D, Redberg RF. Less is more: how less health care can result in better health. Arch Intern Med. 2010;170(9):749-750.
6. Pickering TG. Now we are sick: labeling and hypertension. J Clin Hypertens (Greenwich). 2006; 8(1):57-60.
7. Ogedegbe G. Labeling and hypertension: it is time to intervene on its negative consequences. Hypertension. 2010;56(3):344-345.
8. Moses H III, Matheson DHM, Dorsey ER, George BP, Sadoff D, Yoshimura S. The anatomy of health care in the United States. JAMA. 2013;310(18):1947-1963.
9. Krumholz HM. Variations in health care, patient preferences, and high-quality decision making. JAMA. 2013;310(2):151-152.
10. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-314.
11. Boynton PM, Greenhalgh T. Selecting, designing, and developing your questionnaire. BMJ. 2004;328(7451):1312-1315.
12. Baars JE, Siegel CA, Kuipers EJ, van derWoude CJ. Patients perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel disease. Digestion. 2009;79 (1):30-35.
13. Bernstein SN, Matalon-Grazi S, Rosenn BM. Trial of labor versus repeat cesarean: are patients making an informed decision? Am J Obstet Gynecol. 2012;207(3):e1-e6.
14. Coo H, OConnor KS, Hunter D.Womens knowledge of hormone therapy. Patient Educ Couns. 2001;45(4):295-301.
15. Fagerlin A, Sepucha KR, Couper MP, Levin CA, Singer E, Zikmund-Fisher BJ. Patients knowledge about 9 common health conditions: the DECISIONS survey. Med Decis Making. 2010;30(5)(suppl):35S-52S.
16. Hoffman RM, Lewis CL, Pignone M, et al. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010;30(5)(suppl):53S-64S.
17. Habib SB, Sonoda L, See TC, Ell PJ, Groves AM. How do patients perceive the benefits and risks of peripheral angioplasty? implications for informed consent. J Vasc Interv Radiol. 2008;19(2, pt 1):177-181.
18. Hudson B, Zarifeh A, Young L,Wells JE. Patients expectations of screening and preventive treatments. Ann FamMed. 2012;10(6):495-502.
19. Kee F, McDonald P, Gaffney B. Risks and benefits of coronary angioplasty: the patients perspective: a preliminary study. Qual Health Care. 1997;6(3):131-139.
20. Lee SJ, Fairclough D, Antin JH,Weeks JC. Discrepancies between patient and physician estimates for the success of stem cell transplantation. JAMA. 2001;285(8):1034-1038.
21. Lytsy P,Westerling R. Patient expectations on lipid-lowering drugs. Patient Educ Couns. 2007;67 (1-2):143-150.
22. Mancini J, Nogus C, Adenis C, et al. Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing. Eur J Cancer. 2006;42(7):871-881.
23. Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst. 2002;94(20):1564-1569.
24. Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol. 1998;16(2):515-521.
25. Schonwetter RS, Teasdale TA, Taffet G, Robinson BE, Luchi RJ. Educating the elderly: cardiopulmonary resuscitation decisions before and after intervention. J AmGeriatr Soc. 1991;39(4): 372-377.
26. Siegel CA, Levy LC, Mackenzie TA, Sands BE. Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(1):1-6.
27. Smith D, Loewenstein G, Jepson C, Jankovich A, Feldman H, Ubel P. Mispredicting and misremembering: patients with renal failure overestimate improvements in quality of life after a kidney transplant. Health Psychol. 2008;27(5):653-658.
28. Watson DR, Wilkinson TJ, Sainsbury R, Kidd JE. The effect of hospital admission on the opinions and knowledge of elderly patients regarding cardiopulmonary resuscitation. Age Ageing. 1997; 26(6):429-434.
29. Wee CC, Jones DB, Davis RB, Bourland AC, Hamel MB. Understanding patients value of weight loss and expectations for bariatric surgery. Obes Surg. 2006;16(4):496-500.
30. Weymiller AJ, Montori VM, Jones LA, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007;167(10):1076-1082.
31. Barratt A, Cockburn J, Furnival C, McBride A, Mallon L. Perceived sensitivity of mammographic screening: womens views on test accuracy and financial compensation for missed cancers. J Epidemiol Community Health. 1999;53(11):716-720.
32. Basama FM, Leonard B, Leighton M. Audit: womens perception and knowledge of the 20 weeks anomaly scan. J Obstet Gynaecol. 2004;24 (1):44-46.
33. BlackWC, Nease RF Jr, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst. 1995;87(10):720-731.
34. Chamot E, Perneger TV.Misconceptions about efficacy of mammography screening: a public health dilemma. J Epidemiol Community Health. 2001;55(11):799-803.
35. Cockburn J, Redman S, Hill D, Henry E. Public understanding of medical screening. J Med Screen. 1995;2(4):224-227.
36. Domenighetti G, DAvanzo B, Egger M, et al. Womens perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol. 2003;32(5):816-821.
37. Gekas J, Gondry J, Mazur S, Cesbron P, Thepot F. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenat Diagn. 1999;19(1):1-7.
38. Gigerenzer G, Mata J, Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst. 2009;101(17):1216-1220.
39. Groves AM, Kayani I, Syed R, Gacinovic S, Nagabushan N, Ell PJ. Myocardial perfusion scintigraphy: patients perception of benefit and risk. Nucl Med Commun. 2004;25(12):1219-1222.
40. Haakenson CP, Vickers KS, Cha SS, et al. Efficacy of a simple, low-cost educational intervention in improving knowledge about risks and benefits of screening mammography. Mayo Clin Proc. 2006;81(6):783-791.
41. Haggstrom DA, Schapira MM. Black-white differences in risk perceptions of breast cancer survival and screening mammography benefit. J Gen Intern Med. 2006;21(4):371-377.
42. Lewis CL, Pignone MP, Sheridan SL, Downs SM, Kinsinger LS. A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old. J Gen Intern Med. 2003;18(11):875-883.
43. Neptune SM, Hopper KD, Matthews YL. Risks associated with the use of IV contrast material: analysis of patients awareness. AJR AmJ Roentgenol. 1994;162(2):451-454.
44. Philips Z, Johnson S, Avis M, Whynes DK. Human papillomavirus and the value of screening: young womens knowledge of cervical cancer. Health Educ Res. 2003;18(3):318-328.
45. Philips Z, AvisM,Whynes DK. Knowledge of cervical cancer and screening among women in east-central England. Int J Gynecol Cancer. 2005;15 (4):639-645.
46. Schwartz LM,Woloshin S, Sox HC, Fischhoff B, Welch HG. US womens attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320(7250):1635-1640.
47. Sin HK,Wong CS, Huang B, Yiu KL,WongWL, Chu YC. Assessing local patients knowledge and awareness of radiation dose and risks associated with medical imaging: a questionnaire study. J Med Imaging Radiat Oncol. 2013;57(1):38-44.
48. Watson E, Hewitson P, Brett J, et al. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on mens knowledge, attitudes and intention to be tested. Patient Educ Couns. 2006;63(3):367-379.
49. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for theWomens Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from theWomens Health Initiative randomized controlled trial. JAMA. 2002;288(3): 321-333.
50. Weinstein ND. Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med. 1987;10 (5):481-500.
51. Woolf SH. The price of false beliefs: unrealistic expectations as a contributor to the health care crisis. Ann FamMed. 2012;10(6):491-494.
52. Keitz SA, Stechuchak KM, Grambow SC, Koropchak CM, Tulsky JA. Behind closed doors: management of patient expectations in primary care practices. Arch Intern Med. 2007;167(5):445-452.
53. Herndon MB, Schwartz LM,Woloshin S, et al. Older patients perceptions of unnecessary tests and referrals: a national survey of Medicare beneficiaries. J Gen Intern Med. 2008;23(10):1547-1554.
54. Rao JK,Weinberger M, Kroenke K. Visit-specific expectations and patient-centered outcomes: a literature review. Arch FamMed. 2000;9(10): 1148-1155.
55. Mustafa M,Wood F, Butler CC, Elwyn G. Managing expectations of antibiotics for upper respiratory tract infections: a qualitative study. Ann FamMed. 2014;12(1):29-36.
56. Campbell EG, Regan S, Gruen RL, et al. Professionalism in medicine: results of a national survey of physicians. Ann Intern Med. 2007;147(11): 795-802.
57. Sapre N, Mann S, Elley CR. Doctors perceptions of the prognostic benefit of statins in patients who have hadmyocardial infarction. Intern Med J. 2009; 39(5):277-282.
58. Rothberg MB, Sivalingam SK, Ashraf J, et al. Patients and cardiologists perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med. 2010;153 (5):307-313.
59. Wegwarth O, Gigerenzer G. Overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med. 2013;173(22):2086-2087.
60. Barratt AL, Glasziou PP. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment? Med J Aust. 2012;196(11):681.
61. Doust J, Del Mar C. Why do doctors use treatments that do not work? BMJ. 2004;328 (7438):474-475.
62. Lin GA, Dudley RA, Redberg RF. Cardiologists use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007;167(15):1604-1609.
63. Prasad V, Ho N. Why do we continue to adopt medical practices based on pathophysiology alone when we should be insisting on clinical trials? J Clin Epidemiol. 2014;67(4):361-363.
64. Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA. 2008;299(23):2789-2791.
65. Woloshin S, Schwartz LM, Tremmel J,Welch HG. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet. 2001;358(9288):1141-1146.
66. Vater LB, Donohue JM, Arnold R, White DB, Chu E, Schenker Y. What are cancer centers advertising to the public?: a content analysis. Ann Intern Med. 2014;160(12):813-820.
67. Gummersbach E, Piccoliori G, Zerbe CO, et al. Are women getting relevant information about mammography screening for an informed consent: a critical appraisal of information brochures used for screening invitation in Germany, Italy, Spain and France. Eur J Public Health. 2010;20(4):409-414.
68. Jrgensen KJ, Gtzsche PC. Content of invitations for publicly funded screening mammography. BMJ. 2006;332(7540):538-541.
69. Moynihan R, Bero L, Ross-Degnan D, et al. Coverage by the news media of the benefits and risks of medications. N Engl J Med. 2000;342(22): 1645-1650.
70. Cassels A, HughesMA, Cole C,Mintzes B, Lexchin J,McCormack JP. Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs. CMAJ. 2003;168(9):1133-1137.
71. Schwitzer G. Addressing tensions when popular media and evidence-based care collide. BMC Med Inform Decis Mak. 2013;13(suppl 3):S3.
72. Schwitzer G. A guide to reading health care news stories. JAMA Intern Med. 2014;174(7):1183-1186.
73. Jrgensen KJ, Klahn A, Gtzsche PC. Are benefits and harms in mammography screening given equal attention in scientific articles? a cross-sectional study. BMC Med. 2007;5:12.
74. Heleno B, Thomsen MF, Rodrigues DS, Jrgensen KJ, Brodersen J. Quantification of harms in cancer screening trials: literature review. BMJ. 2013;347:f5334.
75. Zorzela L, Golder S, Liu Y, et al. Quality of reporting in systematic reviews of adverse events: systematic review. BMJ. 2014;348:f7668.
76. Hoffmann TC, Lgar F, Simmons MB, et al. Shared decision making: what do clinicians need to know and why should they bother? Med J Aust. 2014;201(1):35-39.
77. Hoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision making. JAMA. 2014;312(13):1295-1296.
78. Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Older adults and forgoing cancer screening: I think it would be strange. JAMA Intern Med. 2013;173(7):526-531.
79. Stacey D, Lgar F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1: CD001431.
80. Schwartz LM,Woloshin S,Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009;150(8):516-527.
81. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801-1802.
82. Schwartz LM,Woloshin S. The Drug Facts Box: improving the communication of prescription drug information. Proc Natl Acad Sci U S A. 2013;110(suppl 3):14069-14074.
83. Alston C, Paget L, Halvorson G, et al. CommunicatingWith Patients on Health Care Evidence: Discussion Paper.Washington, DC: Institute of Medicine; 2012.
84. Coulter A, Jenkinson C. European patients views on the responsiveness of health systems and healthcare providers. Eur J Public Health. 2005;15 (4):355-360.
85. Cout N, Desroches S, Robitaille H, et al. Assessments of the extent to which health-care providers involve patients in decision making: A systematic review of studies using the OPTION instrument [published online ahead of print March 4, 2013]. Health Expect. doi: 10.1111/hex.12054.
86. Hoffmann TC, Bennett S, Tomsett C, Del Mar C. Brief training of student clinicians in shared decision making: a single-blind randomized controlled trial. J Gen Intern Med. 2014;29(6):844-849.
87. King J, Moulton B. Group Healths participation in a shared decision-making demonstration yielded lessons, such as role of culture change. Health Aff (Millwood). 2013;32(2):294-302.
88. Elwyn G, Scholl I, Tietbohl C, et al. Manymiles to go : a systematic review of the implementation of patient decision support interventions into routine clinical practice. BMC Med Inform Decis Mak. 2013;13(suppl 2):S14.
89. Lgar F,Witteman HO. Shared decision making: examining key elements and barriers to adoption into routine clinical practice. Health Aff (Millwood). 2013;32(2):276-284.
90. Krumholz HM. Informed consent to promote patient-centered care. JAMA. 2010;303(12):1190-1191.
91. Marshall IJ,Wolfe CD, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345:e3953.
92. Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? a study of patients expectation of benefit from preventive drugs. Clin Med. 2002;2(6):527-533.
93. Joosten EA, DeFuentes-Merillas L, deWeert GH, Sensky T, van der Staak CPF, de Jong CA. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77(4):219-226.
94. Schwartz LM,Woloshin S, Fowler FJ Jr,Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78.